Neil Kumar is CEO at BridgeBio Pharma, Inc. (BBIO). They have made 23 open-market trades across 2 companies since 2018, most recently 2026-09-17.
CIK 0001742485
4 open-market purchases totalling $171.2M since 2018, against 19 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EIDX | 24,575,501 | $3.0B |
| BBIO | 495,686 | $32.9M |
| Total | $3.0B |
Shares reported on the most recent Form 4, priced at the 2026-09-21 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BBIO | SELL · 10b5-1 | 2026-09-17 | 2026-09-21 | $69.08 | $691K | -0.0% | — | — |
| BBIO | SELL · 10b5-1 | 2026-08-18 | 2026-08-20 | $82.86 | $3.7M | -7.2% | -19.3% | — |
| BBIO | SELL · 10b5-1 | 2026-06-04 | 2026-06-08 | $67.72 | $4.6M | -3.6% | +14.1% | +8.9% |
| BBIO | SELL · 10b5-1 | 2026-05-21 | 2026-05-26 | $69.44 | $1.8M | -0.5% | +2.6% | +19.4% |
| BBIO | SELL · 10b5-1 | 2026-05-07 | 2026-05-11 | $67.39 | $5.3M | +8.5% | +4.0% | +30.7% |
| BBIO | SELL · 10b5-1 | 2026-04-09 | 2026-04-13 | $74.61 | $6.0M | -8.4% | -12.3% | +6.1% |
| BBIO | SELL · 10b5-1 | 2026-03-12 | 2026-03-16 | $68.76 | $10.9M | +3.4% | +10.7% | -3.1% |
| BBIO | SELL · 10b5-1 | 2026-02-19 | 2026-02-23 | $71.39 | $2.0M | -2.6% | +5.4% | -0.3% |
| BBIO | SELL | 2026-02-10 | 2026-02-12 | $71.86 | $5.7M | -14.2% | -8.4% | -11.5% |
| BBIO | SELL | 2026-01-08 | 2026-01-12 | $75.54 | $6.0M | +2.3% | -3.7% | +2.3% |
| BBIO | SELL · 10b5-1 | 2025-12-15 | 2025-12-16 | $74.64 | $4.5M | +0.4% | +1.2% | -5.7% |
| BBIO | SELL · 10b5-1 | 2025-12-04 | 2025-12-08 | $73.80 | $9.5M | +0.1% | +0.3% | -11.4% |
| BBIO | SELL · 10b5-1 | 2025-11-20 | 2025-11-24 | $65.84 | $3.4M | +4.2% | +8.3% | -3.9% |
| BBIO | SELL · 10b5-1 | 2025-11-06 | 2025-11-10 | $62.28 | $9.9M | +2.4% | +15.2% | +14.5% |
| BBIO | SELL · 10b5-1 | 2025-10-08 | 2025-10-10 | $54.79 | $5.5M | -4.9% | +12.2% | +31.9% |
| BBIO | SELL · 10b5-1 | 2025-09-04 | 2025-09-08 | $51.91 | $6.2M | -1.4% | +2.2% | +37.3% |
| BBIO | SELL · 10b5-1 | 2025-08-20 | 2025-08-22 | $48.81 | $2.5M | +6.3% | +5.7% | +32.5% |
| BBIO | SELL · 10b5-1 | 2025-08-07 | 2025-08-11 | $45.84 | $3.7M | +3.5% | +9.2% | +29.5% |
| BBIO | SELL · 10b5-1 | 2025-07-01 | 2025-07-03 | $42.63 | $3.4M | +7.6% | +9.1% | +22.2% |
| BBIO | SELL · 10b5-1 | 2025-05-19 | 2025-05-20 | $33.37 | $4.2M | +6.3% | +25.1% | +46.9% |
| BBIO | SELL · 10b5-1 | 2025-04-22 | 2025-04-24 | $34.11 | $2.6M | +4.9% | -6.0% | +31.2% |
| BBIO | SELL · 10b5-1 | 2025-03-25 | 2025-03-27 | $36.87 | $2.8M | -16.2% | -0.3% | +23.3% |
| BBIO | SELL · 10b5-1 | 2025-02-25 | 2025-02-27 | $33.57 | $5.0M | -4.3% | +2.3% | -4.6% |
| BBIO | SELL · 10b5-1 | 2025-02-19 | 2025-02-19 | $36.14 | $2.3M | -16.2% | -11.8% | -14.4% |
| BBIO | SELL · 10b5-1 | 2025-01-28 | 2025-01-30 | $36.31 | $43.4M | -13.1% | -7.9% | +7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.